AccuStem Sciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
November 13, 2023 at 06:34 am EST
AccuStem Sciences, Inc. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported net loss was USD 0.598525 million compared to USD 0.899125 million a year ago. Basic loss per share from continuing operations was USD 0.05 compared to USD 0.08 a year ago.
For the nine months, net loss was USD 1.8 million compared to USD 2.77 million a year ago. Basic loss per share from continuing operations was USD 0.16 compared to USD 0.25 a year ago.